LB Pharmaceuticals Stock (NASDAQ:LBRX)
Previous Close
$23.25
52W Range
$13.36 - $27.55
50D Avg
$23.59
200D Avg
$19.73
Market Cap
$620.84M
Avg Vol (3M)
$228.68K
Beta
-5.92
Div Yield
-
LBRX Company Profile
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.